MedPath

Velcade

Brand Name: Velcade

Generic Name: Bortezomib

Active
Registration Number

DR-XY39166

Dosage Form

Powder For Injection (IV/SC)

Issuance Date

June 11, 2021

Expiry Date

March 11, 2026

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength3.5 mg/vial
PackagingUSP Type I Clear Glass Vial x 1 (Box of 1's)

Classification

C
Classification
Prescription Drug (RX)
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

BortezomibActive
Monograph: Bortezomib

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform